1 insider bought shares over the last 90 days, the latest by Sarah MacAulay and PCA, filed 17 Aug 2026.
Bellevue Healthcare Trust PLC is a listed company. Filings by its managers are published through RNS (LSE). Between 21 October 2025 and 21 October 2026, 5 insiders published 8 filings.
Only purchases show up on the open market, 8 purchases in all, filed by 5 insiders. The amount is not disclosed for 8 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 4 senior executives and 1 board member.
For context, the typical company on the same exchange (median of 831 companies) published 6 filings over the same period, against 8 filings here. Since 2017, the database holds 83 purchases and no sales by insiders of the company.
The most recent open-market purchase was published on 17 August 2026, 65 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades.
In the same market, recent insider purchases at CMC Markets plc also feature in our signals. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended November 2025 · cache
25 of 91 declarations
Bellevue Healthcare Trust PLC is an investment company focused on the healthcare sector. It is listed on the London Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendationsSource: Wikidata (CC0).